Local elevation of CCL22: A new trend in immunotherapy (skin model)
Open Access
- 1 November 2016
- journal article
- Published by Elsevier in Journal of Cellular Immunotherapy
- Vol. 2 (2) , 79-84
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivoJournal of Experimental Medicine, 2012
- Bioinspired Controlled Release of CCL22 Recruits Regulatory T Cells In VivoAdvanced Materials, 2012
- Prevention of Type 1 Diabetes in the Rat With an Allele-Specific Anti–T-Cell Receptor AntibodyDiabetes, 2012
- Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic isletsJournal of Clinical Investigation, 2011
- Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cellsJournal of Allergy and Clinical Immunology, 2011
- Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo LesionsPLOS ONE, 2011
- Skin-Resident T Cells: The Ups and Downs of On Site ImmunityJournal of Investigative Dermatology, 2010
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsJournal of Experimental Medicine, 2008
- Dexamethasone transforms lipopolysaccharide‐stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin‐10 production in T cellsImmunology, 2008
- Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: Implications for the pathophysiology of vitiligoEuropean Journal of Cell Biology, 2004